Søgning på udtrykket 'covid' giver 84 resultater


Dokumenter [11] Sider [3] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [11]

Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Invitation til møde den 20. maj 2022

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19

Sider [3]

… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo…

…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne. Apexxnar er en…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Journal of Medical Virology
22.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
International Journal of Infectious Diseases
22.05.2024
The US National Institute of Health (NIH) launched the RECOVER initiative in 2021, a billion-dollar national research network, aimed at understanding, preventing, and treating long COVID [1]. Also in 2021, UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) funded long COVID research studies with £18.5 million, to understand the genetic, biological, social, and environmental signatures and pathways of long COVID [2]. These projects have increased awareness of long COVID
BMJ Open
22.05.2024
. Objective. The objective was to analyse how the pandemic affected primary care access and comprehensiveness in chronic disease management by comparing primary care patterns before and during the early COVID-19 pandemic. . Design. We conducted a quasi-experimental pre–post design cohort study and reported indicators for the 21 months before and after the onset of the COVID-19 pandemic. . Setting. We used electronic medical record data from primary care clinics enrolled in the Canadian Primary Care Sent…
Clinical Microbiology Reviews
22.05.2024
Clinical Microbiology Reviews, Ahead of Print.
PLoS One Infectious Diseases
22.05.2024
by Tanapat Tassaneeyasin, Somnuek Sungkanuparph, Sirawat Srichatrapimuk, Attawit Charoensri, Kanin Thammavaranucupt, Kulapong Jayanama, Suppachok Kirdlarp . Backgrounds In critically ill patients with COVID-19, secondary infections are potentially life-threatening complications. This study aimed to determine the prevalence, clinical characteristics, and risk factors of CMV reactivation among critically ill immunocompetent patients with COVID-19 pneumonia. Methods A retrospective cohort study was conducted…
PLoS One Infectious Diseases
22.05.2024
…Jennifer Hadlock, Qi Wei, George A. Diaz . Background The Pneumonia Score Index (PSI) was developed to estimate the risk of dying within 30 days of presentation for community-acquired pneumonia patients and is a strong predictor of 30-day mortality after COVID-19. However, three of its required 20 variables (skilled nursing home, altered mental status and pleural effusion) are not discreetly available in the electronic medical record (EMR), resulting in manual chart review for these 3 factors. The goal of …
PLoS One Infectious Diseases
22.05.2024
by F. Marlijn Booij-Tromp, Nicole J. van Groningen, Sebastian Vervuurt, Juanita A. Haagsma, Bas de Groot, Heleen Lameijer, Menno I. Gaakeer, Jelmer Alsma, Pleunie P. M. Rood, Rob J. C. G. Verdonschot, Marna G. Bouwhuis . Introduction The COVID-19 outbreak disrupted regular health care, including the Emergency Department (ED), and resulted in insufficient ICU capacity. Lockdown measures were taken to prevent disease spread and hospital overcrowding. Little is known about the relationship of stringency of lo…
Journal of Medical Virology
21.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
Clinical Microbiology and Infection
21.05.2024
We read with great interest the article by Meijer et al. on behalf of the Israeli Society of Infectious Diseases on the prolonged coronavirus diseases (COVID-19) that develops in immunocompromised subjects, termed as persistent COVID-19 (pCOVID) [1].
BMC Infectious Diseases
21.05.2024
. Abstract. . Background. While numerous studies have evaluated the real-world performance of rapid antigen tests (RATs), data on the effect of Omicron sublineages such as XBB and reinfections on RAT performance is limited. We assessed the performance of RATs and factors associated with RAT-negative results among individuals who tested SARS-CoV-2-positive by reverse transcription-polymerase chain reaction (RT-PCR). . …
Lancet Infectious Diseases
21.05.2024
Loss is pervasive, and COVID-19 accentuated its inescapable nature. Loss of life, health, economic security, and social well-being affected us all. Loss and trauma in the COVID-19 era is a collection of essays originally published in the Journal of Loss and Trauma. It is a scholarly resource for practitioners who work with clients enduring COVID-19-related problems, and for academics whose research covers these psychological fields.
International Journal of Infectious Diseases
20.05.2024
The most recent Global Burden of Disease (GBD) Study has ranked stroke as the second leading cause of death and the third contributor to disability globally [1]. The Coronavirus Disease 2019 (COVID-19) pandemic introduced an additional complexity by adding a potential risk factor for stroke [2] and accelerating the onset of death among individuals susceptible to all-cause mortality, including stroke [3].
Infection
19.05.2024
. Abstract. . Purpose. Coronavirus disease 2019 (COVID-19) and non-COVID-19 community-acquired pneumonia (NC-CAP) often result in hospitalization with considerable risks of mortality, ICU treatment, and long-term morbidity. A comparative analysis of clinical outcomes in COVID-19 CAP (C-CAP) and NC-CAP may improve clinical management. . . . Methods. Using pr…
Infection
18.05.2024
. Abstract. . Purpose. Coronavirus disease 2019 (COVID-19) and non-COVID-19 community-acquired pneumonia (NC-CAP) often result in hospitalization with considerable risks of mortality, ICU treatment, and long-term morbidity. A comparative analysis of clinical outcomes in COVID-19 CAP (C-CAP) and NC-CAP may improve clinical management. . . . Methods. Using pr…
Journal of Medical Virology
18.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
BMJ Open
17.05.2024
. Objective. To investigate current care for people with Long COVID in England. . Design. In-depth, semistructured interviews with people living with Long COVID and Long COVID healthcare professionals; data analysed using thematic analysis. . Setting. National Health Service England post-COVID-19 services in six clinics from November 2022 to July 2023. . Participants. 15 healthcare professionals and 21 people living with Long COVID currently attending or discharged (18 female; 3 male). . Results. Health…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Statens Serum Institut
16.05.2024
Nyt studie viser, at efterårets covid-19-vaccine er mindre effektiv over for de nye covid-varianter, der har domineret smittebilledet den forgangne vinter. Men vaccinen har stadig en væsentlig effekt.
Medscape Infectious Diseases
16.05.2024
CDC experts share what clinicians should know about COVID-19 prevention in immunocompromised patients. . CDC Expert Commentary
Medscape Infectious Diseases
15.05.2024
A leading light in immunobiology takes us through long COVID, nasal vaccines, and the next frontier of the field. . Medscape
Medscape Infectious Diseases
8.05.2024
There is no link between the SARS-CoV-2 vaccine and increased risk for new-onset seizure activity, results from a new meta-analysis showed. . Medscape Medical News
Medscape Infectious Diseases
2.05.2024
The mRNA technology enables quick and flexible responses to new variants of pathogens and rapid scale-up in production, said one researcher. . Medscape Medical News
Medscape Infectious Diseases
2.05.2024
Despite safety and effectiveness, COVID vaccination rates remained lower than flu vaccination rates — and resulting death rates put this in a grim light. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
26.04.2024
This report describes a recommendation from the Advisory Committee on Immunization Practices that all people ages ≥65 years and older receive one additional dose of any updated (2023-2024 Formula) COVID-19 vaccine.
Medscape Infectious Diseases
24.04.2024
The opposite was seen in women when compared with matched control individuals without diabetes. . Medscape UK
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes COVID-19 rates, hospitalizations, and vaccination coverage among nursing home residents.
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes the duration of protection provided by the original monovalent COVID-19 vaccines.
Medscape Infectious Diseases
18.04.2024
The World Health Organization and around 500 experts have agreed for the first time what it means for a disease to spread through the air, in a bid to avoid the confusion. . Reuters Health Information
ECDC COVID-19 updates
17.04.2024
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
Medscape Infectious Diseases
16.04.2024
Where long COVID treatment and research is right now — and where it's going. . Medscape Medical News
Medscape Infectious Diseases
15.04.2024
Primary care doctors who serve marginalized communities had the highest rate of patients unvaccinated against COVID-19 in a recent study. . Medscape Medical News
Eurosurveillance latest updates
12.04.2024
…ropean Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season. .
Morbidity and Mortality Weekly Report (MMWR)
12.04.2024
This report describes a review of Oregon death certificate data to assess whether young people in Oregon might be dying after receiving a COVID-19 vaccine.
Morbidity and Mortality Weekly Report (MMWR)
12.04.2024
This report describes COVID-19 vaccination coverage in the World Health Organization African Region during 2021-2023.
ECDC COVID-19 updates
8.04.2024
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.
Medscape Infectious Diseases
5.04.2024
Pandemic burnout has persisted with doctors just as long COVID has with patients, with some reluctant to seek treatment. . Medscape Medical News

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.12.4
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.739 s

Cookies og privatliv